Sonoma Pharmaceuticals

Sonoma Pharmaceuticals, with its slogan "Empathy lead, Science driven," is a global healthcare leader dedicated to developing and commercializing innovative wound care and dermatological solutions. Established in 1999 in the United States, the company offers safe early-intervention products that ensure fast relief without side effects or other limitations. It has over 20 years of experience in harnessing the patented Microcyn® Technology to create a diverse portfolio that caters to the needs of patients and healthcare professionals. Sonoma's mission is to improve patient outcomes by providing reliable, unique solutions that facilitate optimal conditions for wound care and skin health. The company collaborates with industry experts and community partners to bring groundbreaking products to the market, constantly pushing the boundaries of what's possible in healthcare. Its $1.70M Post-IPO Equity investment on 26 October 2023 underscores investor confidence in the company's potential to drive innovation and address unmet needs in the Health Care industry.